Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Vilanterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 12 Jan 2012 Results published in Chest.
- 22 Sep 2010 Safety results were presented at the 20th Annual Congress of the European Respiratory Society.
- 22 Sep 2010 Results presented at the European Respiratory Society congress, according to a GSK media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History